News

Media

Conferences

Publications

Clinical

Events

Resources

Diana Levytska

home / authors / diana-levytska

Articles

Case Studies: September 2022

Case Studies: September 2022

Diana Levytska;Stefanie C. Nigro, PharmD, BCACP, CDCES

September 22nd 2022

How would you respond to these patient questions?

Read More

Latest Updated Articles

Anatomy of Human Heart on medical background. 3d render - Image credit: ckybe | stock.adobe.com

Published: March 10th 2025 | Updated: March 21st 2025

Pharmacists Will Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM

Image credit: toeytoey | stock.adobe.com

Published: March 12th 2025 | Updated: March 18th 2025

MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations

Blood test for graft-vs-host-disease (GVHD) -- Image credit: MdBabul | stock.adobe.com

Published: February 26th 2025 | Updated: March 14th 2025

Navigating Steroid-Refractory GVHD Treatment: A Pharmacist’s Guide to Medication Management

fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com

Published: March 7th 2025 | Updated: March 10th 2025

FDA Approves Interchangeable Biosimilar to Xolair

Benjamin Franklin on US dollar surrounded by pills | Image Credit: © Cagkan - stock.adobe.com

Published: January 22nd 2025 | Updated: January 28th 2025

Reversal of Executive Order 14087 Raises Questions About Future Drug Pricing Reforms

A pregnant woman sits on a bed, holding a glass of water in one hand while preparing to take prenatal vitamins in the other. She appears thoughtful and focused on her health - Image credit: Prostock-studio | stock.adobe.com

Published: December 18th 2024 | Updated: January 2nd 2025

Study Shows Choline and Iodine Are Missing Links in Prenatal Supplements

Recent Content

FDA Grants Accelerated Approval to Atrasentan for Proteinuria Reduction in Primary IgA Nephropathy

FDA Grants Accelerated Approval to Atrasentan for Proteinuria Reduction in Primary IgA Nephropathy

Visualization of a CAR T-cell | Image Credit: © DruZhi Art - stock.adobe.com

Nivolumab May Restore T-Cell Fitness Following CAR T-Cell Therapy in Patients With Multiple Myeloma

Wegovy injection pens in different dosages in a pile - Image credit: Patrick Bay Damsted | stock.adobe.com

The GLP-1 Conundrum: Insights from the 2025 Pharmacy in Focus Report

ELCC 2025: Amivantamab Plus Lazertinib Effective in EGFR-Mutated NSCLC Versus Standard of Care

ELCC 2025: Amivantamab Plus Lazertinib Effective in EGFR-Mutated NSCLC Versus Standard of Care

View More Recent Content

Consent Preferences

Clinical Forums

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.